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Figure 1. Products of Oxidative Transformations of Polyunsaturated
Essential Fatty Acids
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Previewsleukocytes. Unlike the struc-
turally related normal DHA
dihydroxylated product ob-
tained by the action of lipoxy-
genase on DHA, in which the
17-OH has the S-absolute
configuration, the new pro-
duct which is produced by
the aspirin-acetylated COX-2
enzyme has a 17R-OH con-
figuration (Figure 1). Com-
plete structural characteri-
zation was carried out by
elegant synthetic and analyt-
ical work as with the earlieridentified neuroprotectins (Marcheselli
et al., 2010). This newprotectin has potent
antiinflammatory actions and stimulates
resolution by activating macrophages
and assists in clearing sites of inflamma-
tion by stimulating macrophages to up-
take dead leukocytes and other cellular
debris.
The structural characterization of these
intriguing and very potent oxygenated
lipid molecules coupled with the careful
characterization of their immunomodulat-
ing properties opens the door for the
development of novel therapeutics in the
all-important field of inflammation. Char-
acterization of the protein targets forthese molecules is still at the early stages
while correlation between their structures
and activities is incomplete. Progress in
these fronts should provide the basis
for thoughtful target-based drug design
to produce more biochemically stable
and therapeutically targeted medications.
Serhan’s finding also suggests the com-
bined use of DHA and aspirin as an attrac-
tive therapeutic avenue for the treatment
of inflammatory conditions.REFERENCES
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The development of a method for the amplification of PNA tags (Svensen et al., in this issue of Chemistry &
Biology) should expand the range of biological targets amenable to screening using PNA-encoded combina-
torial libraries and thus facilitate the discovery of new biologically useful agents.The screening of libraries of molecules to
identify those with desirable biological
properties is fundamental to the drug
discovery process and chemical biology
studies in general. Solid-phase split-
and-mix combinatorial synthesis tech-
niques can rapidly generate libraries ofvast numbers of compounds suitable for
screening (Maclean et al., 1997; Harris
and Winssinger, 2005; Dı´az-Mocho´n
et al., 2005). However, such libraries are
obtained as complex mixtures, and deter-
mining the chemical identity of any indi-
vidual biologically active member presentis challenging. Toward this end, a number
of chemical-encoding strategies have
been developed where each molecule in
the library becomes associated with (or
incorporates) a unique tag encoding its
unique synthetic history and thus molec-
ular structure. This information can thener Ltd All rights reserved 1209
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Previewsbe revealed by analyzing the tag via a
suitable decoding process.
DNA encoding is arguably the most
widely used tagging method for split-
and-mix libraries, offering opportunities
for parallel and quantitative decoding,
either through the use of microarray
platforms or sophisticated sequencing
methods (Svensen et al., 2011b). Addi-
tionally, peptide nucleic acid (PNA) has
been identified as valuable encoding
alternative to DNA (Harris andWinssinger,
2005). PNA is a DNA mimic that has a
high affinity for DNA, in principle, allowing
the decoding of PNA libraries through
their interface with organized DNA micro-
arrays via sequence-specific hybridiza-
tion (Svensen et al., 2011a). PNA is more
resistant to both chemical and biological
degradation than DNA; there are thus
comparably less restrictions on the
chemistries that can be used to build
PNA-encoded libraries (which could allow
a greater diversity of products to be
generated) and PNA can exist in an envi-
ronment with live cells for a longer period
of time (Svensen et al., 2011a; Svensen
et al., 2011b [this issue of Chemistry &
Biology]). However, a fundamental pro-
blem with PNA encoding is that PNA
cannot be amplified using standard nu-
cleic acid amplification techniques; thus,
if a screen yields a low concentration of
PNA tags (for example, if the biological
target is in relatively scarce amounts),
which are below the level needed for mi-
croarray analysis, then decoding of any
hits is not possible. Svensen et al. now
report a novel method for the amplifica-
tion of hits from a library of PNA-tagged
peptides that addresses this key limita-
tion. Their approach is based around the
indirect DNA amplification of PNA tags,
i.e., PNA to DNA decoding. The authors
describe an overall screening strategy in-
corporating this novel amplification tech-
nique in the context of discovering new
cell surface receptor ligands. This process
involves the following main stages:
1. Incubation of a PNA-encoded pep-
tide library against live cells overex-
pressing a cell surface receptor of
interest1210 Chemistry & Biology 18, October 28, 202. Extraction of the PNA tags
3. Hybridization of the isolated
PNA with a single-stranded DNA
(ssDNA) library complementary to
the original PNA-encoded peptide
library
4. Degradation of the nonhybridized
ssDNA
5. Asymmetric PCR amplification of
the DNA protected by the PNA
with a fluorescent primer-gener-
ated ssDNA
6. Hybridization of the fluorescently
labeled ssDNA with a complemen-
tary DNA microarray to allow de-
coding of the amplified ssDNA
(and hence the PNA tags and their
encoded peptides).
In proof-of-concept work the authors
describe the screening of a 10,000
member PNA-encoded peptide library
with live cells overexpressing members
of two classes of pharmacologically rele-
vant cell surface receptors, either integ-
rins or the CCR6 receptor (a G protein
coupled receptor). New peptide ligands
for two integrins (ayb5 and ayb5) and
CCR6 were discovered, demonstrating
the feasibility of this approach. Indeed,
this strategy may prove to be broadly
applicable for the identification of ligands
for a wide range of cell surface receptors,
which has been a long-standing goal in
medicinal chemistry research. The tech-
nology offers a tool for studying differ-
ences in membrane receptor expression
between different cell types, including
diseased states, which could have impor-
tant implications for the identification of
pharmaceutically relevant receptor drug
targets.
The amplification technique developed
by Svensen et al. represents a significant
advancement in our ability to decode
PNA-tagged libraries; as such, it is ex-
pected to have broad applications be-
yond the remit of discovering new cell
surface receptor ligands. This technology
may prove especially valuable when
screening for hits against biological
targets that are available only in limited
amounts (e.g., due to limited number of
cells or a target that is expressed only in11 ª2011 Elsevier Ltd All rights reservedsmall quantities), which has traditionally
been viewed as challenging (or indeed
impossible) to achieve using PNA-en-
coded libraries. There are several other
significant aspects of this work. As
screening is carried out prior to decoding
and PNA is not degraded under normal
biological conditions, the technology is
suitable for both in vivo as well as in vitro
applications. The use of DNA microarrays
allows information on the interactions
between active compounds and their
targets to by extracted on a compound-
by-compound basis. In principle, the
new decoding strategy could be applied
to the screening of libraries of nonpeptidic
compounds, including small molecules,
which would increase the chemical
universe amenable to screening using
PNA-encoding methods (Svensen et al.,
2011b; Scheuermann et al., 2006). This
is an important consideration given the
growing demand for novel biological
agents from unexplored regions of chem-
ical space (Galloway et al., 2010). Overall
the PNA tag amplification technique
developed by Svensen et al. represents
a significant advancement in the field of
library screening using PNA encoding,
which should facilitate the discovery of
a wide-range of novel biologically useful
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